| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K71781559 |
| PharmacoGx | BRD-K71781559 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ADM | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | CMA1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | CD2AP | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | ASH1L | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | USP51 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | PRTN3 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | KLHL14 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | C14orf79 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.08 |
| mRNA | CEP162 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | PRMT2 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
